NDSN Earnings

NDSN reported its earnings on 2026-02-18, showcasing a revenue of 669.46M against an estimate of 650.83M, resulting in a 2.86% surprise. The EPS was 2.37, surpassing the expected 2.36 by 0.42%. The stock experienced a -1.79% price change on the earnings day and a -1.49% change over the next five days, reflecting market reactions to the results.

Following NDSN's earnings announcement on 2026-02-18, the stock price moved by -1.79% on the day of the release. Over the subsequent five days, it saw a -1.49% change. Historically, NDSN's stock price tends to shift by an average of -1.18% in the 10 days leading up to earnings and -0.33% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate NDSN's annual revenue to reach 711.13M, while the EPS is projected at 2.71. These estimates reflect recent revisions, with revenue estimates revised downward by -0.65% and EPS estimates revised downward by -0.43% over the past three months, indicating analyst expectation in the company's performance.

The correlation between NDSN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were revised downward by -0.65%, while EPS estimates moved revised downward by -0.43%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, NDSN's stock price typically moves by -1.18% in the 10 days before its earnings and -0.33% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 2.71 and revenue of 711.13M.

The earnings call summary indicates stable to positive growth across segments, with notable strength in the medical and ATS segments. The Q&A reveals confidence in overcoming weather impacts and a strong order pipeline. Despite some margin challenges, management maintains a positive outlook with strong incrementals. The company's strategic focus on high-margin areas and disciplined M&A activity further supports a positive sentiment. Overall, the insights suggest a positive market reaction, likely within the 2% to 8% range.